Диссертация (1174256), страница 16
Текст из файла (страница 16)
Raffi, F. The impact of excision of ovarian endometrioma on ovarianreserve: a systematic review and meta-analysis. / F. Raffi, M. Metwally, S. Amer // J.Clin. Endocrinol. Metab. – 2012. – V.97(9). – P.3146–54.10993. Raffi, F. National survey of the current management of endometriomas inwomen undergoing assisted reproductive treatment. / F. Raffi, R.W. Shaw, S.A.Amer // Hum. Reprod. – 2012. – V.27(9). – P.2712–9.94. Suksompong, S. Ovarian reserve evaluation by anti-mullerian hormone inwomen undergoing laparoscopic cystectomy of endometrioma. / S.
Suksompong, S.Dejarkom, S. Petyim, C. Dangrat, D. Orachon, R. Choavaratana // J. Med. Assoc.Thai. – 2012. - V.95(11). – P.1389–95.95. Rustamov, O. Anti-Mullerian hormone: poor assay reproducibility in a largecohort of subjects suggests sample instability. / O. Rustamov, A.
Smith, S.A. Roberts,A.P.Yates, C.Fitzgerald, M.Krishnan et al. // Hum. Reprod. – 2012. – V.27(10). –P.3085–91.96. Fréour, T. Computer-assisted sperm analysis parameters in young fertilesperm donors and relationship with age. / T. Fréour, M.Jean, S.Mirallie, P.Barriere //Syst. Biol. Reprod. Med. – 2012. – V.58(2).
– P.102–106.97. Ruess, M.L. Age and the ovarian follicle pool assessed with transvaginalultrasonography / M.L.Ruess, J.Kline, R.Santos, B. Levin // Am-J-Obstet-Gynecol. 1996. - № 174. - P. 624-627.98. Scheffer, G.J. Quantitative transvaginal two- and three-dimensionalsonography of the ovaries: reproducibility of antral follicle counts / G.J. Scheffer,F.J.Broekmans, L.F. Bancsi et al. // Ultrasound Obstet Gynecol. – 2002.
- №20. P.270-275.99. Gougeon, A. Age-related changes of the population of human ovarianfollicles: increase in the disappearance rate of non-growing and early-growingfollicles in aging women / A.Gougeon, R.Echochard, J.Thalabard // Biol.Reprod.1994.-V.50.-P.653-663.100. Melo, M.A. Antral follicle count (AFC) can be used in the prediction ofovarian response but cannot predict the oocyte/embryo quality or the in vitrofertilization outcome in an egg donation program.
/ MA Melo, N Garrido, C Alvarez,J Bellver, M Meseguer, A Pellicer, J. Remohí // Fertil. Steril. – 2009. – V.91(1). –P.148-56.110101. Faddy, MJ. Follicle dynamics during ovarian ageing. / MJ. Faddy // MolCell Endocrinol. -2000. – V.163(1-2). – P.43-48.102.
Ivarson, S.A. Ultrasonography of the pelvic organs in prepubertal andpostpubertal girls. / SA Ivarson, KO Nilson, PH Pearson // Arch. Dis. child. – 1983. –V.58(5). – P.352-4.103. Josso, N. Anti-Mullerian hormone in early human development.
/ N.Josso,I. Lamarre, J.Y. Picard, P.Berta, N.Davies, N.Monchon, M.Peschanski, R.Jeny //Early Hum. Dev. – 1993. – V.33. – P.91-99.104. Rey, R., Lordereau-Richard I., Carel J.C., Barbec P., Cate R.L., Roger M.,Chaussain J.L., Josso N. Anti-Mullerian hormone and testosterone serum levels areinversely related during normal and precocious pubertal development. / R. Rey,I.Lordereau-Richard, J.C. Carel, P.Barbec, R.L.Cate, M.Roger, J.L.Chaussain,N.Josso // J Clin Endocrinol.
Metab. – 1993. – V.77. – P.1220-1226.105. Hudson, P.L. An immunossay to detect human Mullerian inhibitingsubstance in males and females during normal development. / P.L. Hudson,I.Douglas, P.K. Donahoe et al. // J Clin. Endocrinol. Metab. – 1990. – V.70. – P.1622.106. Jost, A. Problems of fetal endocrinology: the gonadal and hypophysealhormones. / A.Jost // Rec. Progr. Horm. Res.
– 1953. – V.8. – P.379-418.107.Vigier,B.Anti-Mullerianhormone:Alocalorlong-distancemorphogenetic factor? / B.Vigier, J.-Y.Picard, J.Bezard, N.Josso // Hum. Genet. –1981. – V.58. – P.85-90.108. Josso, N., Anti-Mullerian hormone and intersex states. / N.Josso,L.Boussin, B. Knebelmann et al. // Trends Endocrinol. Metab. – 1991. – V.2. –P.227-233.109. Sajjad, Y. Development of the genital ducts and external genitalia in theearly human embryo.
/ Y.Sajjad // Obstet. Gynaecol. Res. – 2010. – V.36(5). – P.92937110. Seifer, D.B. Early follicular serum müllerian-inhibiting substance levels areassociated with ovarian response during assisted reproductive technology cycles. /111D.B.Seifer, DT MacLaughlin, BP Christian, B Feng, RM Shelden // Fertil. Steril. –2002. - V.77(3). – P.468-71.111.
Fanchin, R. Serum anti-Müllerian hormone is more strongly related toovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. / RFanchin, LM Schonäuer, C Righini, J Guibourdenche, R Frydman, J. Taieb //Hum.Reprod. – 2003. - V.18(2). – P.323-7.112. Hazout, A. Serum antimüllerian hormone/müllerian-inhibiting substanceappears to be a more discriminatory marker of assisted reproductive technologyoutcome than follicle-stimulating hormone, inhibin B, or estradiol.
/ A. Hazout, PBouchard, DB Seifer, P Aussage, AM Junca, P Cohen-Bacrie // Fertil. Steril. – 2004.– V.82(5). – P.1323-9.113. Hehenkamp, W.J. Anti-Mullerian hormone levels in thespontaneousmenstrual cycle do not show substantial fluctuation. / WJ Hehenkamp, CW Looman,AP Themmen, FH de Jong, ER TeVelde, FJ. Broekmans // JClin Endocrinol. Metab.– 2006. – V.91(10). – P.4057–63.114. La Marca, A. Serum Anti-Mullerian Hormone levels in women withsecond-ary amenorrhea.
/ A. La Marca, M Pati, R Orvieto, G Stabile, A CarducciArtenisio et al. // Fertil. Steril. – 2006. – V.85. – P.1547–9.115. Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, TewsG. Basal level of anti-Müllerian hormone is associated with oocyte quality instimulated cycles. Hum. Reprod. – 2006. – V.21(8). – P.2022-6.116. Bath, L.E. Depletion of ovarian reserve in young women after treatment forcancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarianultrasound / L.E.
Bath et al. // Hum Reprod. – 2003. – V. 18 (11) – P. 2368–2374.117. van Rooij, IA. Serum antimullerian hormone levels best reflect thereproductive decline with age in normal women with proven fertility: a longitudinalstudy. / IA. van Rooij et al. // Fertil. Steril. – 2005. – V.83(4). – P.979-87.118. van Disseldorp, J. Relationship of serum antimullerian hormone concentration to age at menopause. / J.
van Disseldorp, MJ Faddy, AP Themmen et al. // JClin. Endocrinol. Metab. – 2008. – V.93. – P.2129-34.112119. Massin, N. Evaluation of different markers of the ovarian reserve inpatients presenting with premature ovarian failure. / N Massin, G Méduri, ABachelot, M Misrahi, F Kuttenn, P Touraine // Mol.
Cell Endocrinol. – 2008. –V.282(1-2). – P.95-100.120. Méduri, G. Serum anti-Müllerian hormone expression in women withpremature ovarian failure. / G Méduri, N Massin, J Guibourdenche, A Bachelot, OFiori, F Kuttenn, M Misrahi, P Touraine // Hum.
Reprod. – 2007. – V.22(1). P.117-23121. Massin, N. Significance of ovarian histology in the management of patientspresenting a premature ovarian failure. / N Massin et аl. // Hum. Reprod. – 2004. –V.19(11). – P.2555-60.122. Gougeon, A. Dynamics of human follicular growth: Morphologic,dynamic, and functional aspects. / A. Gougeon // A chapter in The Ovary, secondedition, by Peter Leung. – 2004. – P.21-43.123. Baird, D.T. Ovarian steroid secretion and metabolism in women // In:James V.H.T., Serio M., Giusti G.
(eds.) The Endocrine Function of the HumanOvary.-Academic Press, New York.- 1976.- P. 125-133124. Blandau, R.J. Follicular growth, ovulation and egg transport // In: MackH.C., Tomas C.C. The Ovary. - 1968.125. Block, E. Quantitative morphological investigation of the follicular systemin women / E. Block // Acta Endocrinol.(Kbh).
– 1951. – V.8. – P.33.126. Guidice, L. The insulin like growth factors system in normal and abnormalhuman ovarian follicle development / L. Guidice // Am.J.Med.- 1995.- V.98.- Suppl1A.- P.48-54.127. Hillier, S.G. Control of preovulatory follicular estrogen biosynthesis in thehuman ovary / S.G. Hillier, L.E. Reichert, E.V. Van Hall // J. Clin.
Endocrinol.Metab.-1981.- V.52.-P.847.128. Yamauchi, J. Effects of nitric oxide on ovulation and ovariansteroidogenesis and prostaglandin production in the rabbit / J.Yamauchi, T.Miyazaki,S. Iwasaki et al.// Endocrinology.- 1997.- V.138.- №9.- P.3630-3637.113129. Lass, A. Follicular density in ovarianbiopsy of infertile woman: a novelmethod to assess ovarian reserve.
/ A. Lass, R.Silye, D.C. Abrams et al. // Hum.Reprod. – 1997. – V.12. – P. 1028–1031.130. Vital-Reyes, V. et аl. Ovarian biopsy in infertile patients with ovariandysfunction. / V. Vital-Reyes et аl.// Gynecol. Pathol. – 2006. - V.25(1). – P.90-94.131. Chen, S.L. P rediction of ovarian reserve, poor response and pregnancyoutcome based on basal antral follicle count and age in patients undergoing in vitrofertilization-embryo transfer. / SL Chen, R Xia, X Chen, YQ Luo, LL Wang, YQ Wu,XY Shi, HY Zheng. // Nan Fang Yi Ke Da Xue Xue Bao.
– 2011. – V.31(4). – P.572577.132. Fleming, R. Assessing ovarian response: antral follicle count versus antiMüllerian hormone. / R. Fleming, D.B. Seifer, J.L. Frattarelli, J.Ruman // ReprodBiomed Online. – 2015. – V.31(4). – P.486-96.133. Iliodromiti, S. Technical and performance characteristics of anti-Müllerianhormone and antral follicle count as biomarkers of ovarian response. / S. Iliodromiti,R.A. Anderson, S.M.
Nelson. // Hum. Reprod. Update. – 2015. – V.21(6). – P.698710.134. Goswami, M. Is AMH Level, Independent of Age, a Predictor of Live Birthin IVF? / M. Goswami, D.Nikolaou // J. Hum. Reprod. Sci. – 2017. – V.10(1). –P.24-30.135. Faddy, M. A mathematical model of follicle dynamics in the human ovary./ M. Faddy, R. Gosden // Human. Reprod.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
